Clinical stage gene therapy company using a constellation of proprietary AAV vector technologies to develop novel treatments for central nervous system and lysosomal storage diseases
Company Details
- Employees
- 12
- Founded
- 2017
- Address
- 14189 Nw 129th Way, Alachua,florida 32615,united States
- in****@****ics.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- lacertatherapeutics.com
- Keywords
- AAV gene therapy, AAV manufacturing, AAV capsid variants, AAV capsid engineering, CNS disease, Lysosomal storage disease.
- HQ
- Alachua, Florida
Lacerta Therapeutics Questions
Lacerta Therapeutics's website is lacertatherapeutics.com
Lacerta Therapeutics's LinkedIn profile is https://www.linkedin.com/company/lacerta-therapeutics
Lacerta Therapeutics has
12 employees.
View email and phone details for 12
employees at Lacerta Therapeutics.
Lacerta Therapeutics's industry is
Biotechnology Research
Lacerta Therapeutics's top competitors are
Voyager Therapeutics, Inc.,
Bioflorida, Inc.,
Raaven Therapeutics,
Organabio,
Gbi Bio,
Venture Medical,
Affinia Therapeutics,
Akron Bio,
Andante Biologics, Inc.,
Biostem Technologies (Otc: Bsem).
Lacerta Therapeutics's support email address is info@lacertatherapeutics.com
Lacerta Therapeutics's categories are Biotechnology Research
Lacerta Therapeutics's founding year is 2017
